Skip to content

MERIDIAN BIOSCIENCE INC

Delisted

CIK 794172fmd_1JHN5GNR21H1YDE1DQYCKVB3K2Manufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard

Coverage: Oct 01, 2007 to Dec 31, 2022, 56 periods

Latest annual · FY2022

Millions
Total revenues
333
Gross profit
188
Operating income
54
Net income
42
Free cash flow
74

Latest quarter · Q1 FY2023

Millions
Total revenues
57
Gross profit
32
Operating income
(28)
Net income
(30)
Free cash flow
(5)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2019 to FY2022
+18.3%
Revenue, 5 yearsFY2017 to FY2022
+10.7%
Net income, 5 yearsFY2017 to FY2022
+14.5%

MERIDIAN BIOSCIENCE INC financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2022FY2021ChangeSource
Revenue$333 million$317.9 million+4.8%10-K 2022-11-22 · proof
Gross profit$188.4 million$201.1 million-6.4%10-K 2022-11-22 · proof
Operating income$54.4 million$93 million-41.5%10-K 2022-11-22 · proof
Net income$42.5 million$71.4 million-40.5%10-K 2022-11-22 · proof
Cash from operating activities$82.4 million$66.9 million+23.2%10-K 2022-11-22 · proof
Free cash flow$73.7 million$48.6 million+51.9%10-K 2022-11-22 · proof
Total assets$463.1 million$449.7 million+3%10-K 2022-11-22 · proof
Total liabilities$95 million$121.4 million-21.7%10-K 2022-11-22 · proof
Cash and cash equivalents$81.5 million$49.8 million+63.7%10-K 2022-11-22 · proof
What was MERIDIAN BIOSCIENCE INC's revenue in fiscal 2022?
MERIDIAN BIOSCIENCE INC reported revenue of $333 million for fiscal 2022 (the year ended Sep 30, 2022), against $317.9 million the year before (+4.8%). Source: the 10-K filed with the SEC on Nov 22, 2022. SEC
What was MERIDIAN BIOSCIENCE INC's gross profit in fiscal 2022?
MERIDIAN BIOSCIENCE INC reported gross profit of $188.4 million for fiscal 2022 (the year ended Sep 30, 2022), against $201.1 million the year before (-6.4%). Source: the 10-K filed with the SEC on Nov 22, 2022. SEC
What was MERIDIAN BIOSCIENCE INC's operating income in fiscal 2022?
MERIDIAN BIOSCIENCE INC reported operating income of $54.4 million for fiscal 2022 (the year ended Sep 30, 2022), against $93 million the year before (-41.5%). Source: the 10-K filed with the SEC on Nov 22, 2022. SEC
What was MERIDIAN BIOSCIENCE INC's net income in fiscal 2022?
MERIDIAN BIOSCIENCE INC reported net income of $42.5 million for fiscal 2022 (the year ended Sep 30, 2022), against $71.4 million the year before (-40.5%). Source: the 10-K filed with the SEC on Nov 22, 2022. SEC
What was MERIDIAN BIOSCIENCE INC's cash from operating activities in fiscal 2022?
MERIDIAN BIOSCIENCE INC reported cash from operating activities of $82.4 million for fiscal 2022 (the year ended Sep 30, 2022), against $66.9 million the year before (+23.2%). Source: the 10-K filed with the SEC on Nov 22, 2022. SEC
What was MERIDIAN BIOSCIENCE INC's free cash flow in fiscal 2022?
MERIDIAN BIOSCIENCE INC reported free cash flow of $73.7 million for fiscal 2022 (the year ended Sep 30, 2022), against $48.6 million the year before (+51.9%). Source: the 10-K filed with the SEC on Nov 22, 2022. SEC
What are MERIDIAN BIOSCIENCE INC's total assets?
As of Sep 30, 2022, MERIDIAN BIOSCIENCE INC reported total assets of $463.1 million, against $449.7 million a year earlier (+3%). Source: the 10-K filed with the SEC on Nov 22, 2022. SEC
What are MERIDIAN BIOSCIENCE INC's total liabilities?
As of Sep 30, 2022, MERIDIAN BIOSCIENCE INC reported total liabilities of $95 million, against $121.4 million a year earlier (-21.7%). Source: the 10-K filed with the SEC on Nov 22, 2022. SEC
What are MERIDIAN BIOSCIENCE INC's cash and cash equivalents?
As of Sep 30, 2022, MERIDIAN BIOSCIENCE INC reported cash and cash equivalents of $81.5 million, against $49.8 million a year earlier (+63.7%). Source: the 10-K filed with the SEC on Nov 22, 2022. SEC

Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:794172&period_type=annual&limit=5"

Information only, not investment advice.